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 Spotlight on Research:   
Sudhir Jain, PhD 
The major objective of my work is to evaluate the 
contributions of genetic heterogeneity in 
pathological conditions associated with the 
cardiovascular-renal systems. In particular, we 
study single nucleotide polymorphisms in the 
renin-angiotensin-aldosterone (RAA) axis with an 
eye towards their impact in the genesis of 
hypertension; our long term goal being to identify 
novel molecular targets in this pathway so as to 
facilitate the development of a "tailored" drug 
therapy for hypertension and associated 
pathologies. We have cloned and generated mice 
models of human angiotensinogen gene and its receptor hAT1R 
gene variants. We employ these animal models to dissect differential 
regulation of these target genes whose polymorphisms have been 
reported in the human population. Apart from blood pressure 
regulation, we have proposed the use of these animal models, with 
appropriate modifications, to better understand the role of RAA axis 
in contributing towards metabolic syndrome and vascular lesions of 
the brain and the kidneys. We also aim to study the neural 
regulation of blood pressure by the RAAS in populations 
demonstrating polymorphic changes in the AGT and AT1R genes. 
 
My recent RO1 proposal (percentile score: 6) titled “Hypertension 
and inflammation: novel insights from human angiotensin type 1 
receptor (hAT1R) variants” is designed to analyze how diet and age 
affect the cellular gene regulatory networks and alter hAT1R 
expression using transgenic mouse lines expressing hAT1R variants, 
Haplotype-I and Haplotype-II. Genetic variations that increase 
AT1R can cause pathological outcomes associated with renin 
angiotensin system (RAS) over-activity. We have found that 
genetic variant Haplotype-I overexpress hAT1R and is associated 
with hypertension in Caucasians. Since AT1R up-regulation can 
worsen the pathological outcomes of physiological variables like 
age and diet, understanding its gene- regulation has high 
translational value with significant clinical impact. This can function 
as an “early warning” towards timely and directed therapeutic 
intervention in patients with Haplotype-I of the AT1R gene. 
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Held in the Pathology Conference Room—BSB 414 
Every Wednesday at 1:00 pm 
Date Speaker Affiliation 
30-Jan Paul Arnaboldi, PhD Microbiology and Immunology, NYMC 
6-Feb Zhaohui Feng, PhD, Rutgers 
13-Feb Marcello Cassini, MD, PGY1 Pathology, NYMC 
20-Feb Dr. Yibing Qyang, PhD     Yale Univ 
27-Feb Sarwat Gilani, MD, PGY3 Pathology, NYMC 
6-Mar Dariusz Galkowski, MD, PhD Rutgers 
13-Mar Dana Razzano, MD, PGY3 Pathology, NYMC 
20-Mar Sudhir Jain, PhD           Pathology, NYMC 
27-Mar Shamima Sultana, MD, PGY3 Pathology, NYMC 
3-Apr Ximing J Yang, MD, PhD Northwestern Univ 
10-Apr Rugved Pattarkine, MD, PGY2 Pathology, NYMC 
17-Apr Raj Tiwari, PhD    Interim Chair Microbiology, NYMC 
24-Apr Haiyan Li, MD, PGY1 Pathology, NYMC 
1-May Rebecca Wilcox, MD Univ Vermont 
15-May Austin Guo, PhD Pharmacology, NYMC 
22-May 
Dana Razzano, MD, PGY3 
Special Seminar on Global Health 
Pathology, NYMC 
5-Jun Joann Sweasy, PhD Yale 
12-Jun 
Malini Harigopal, MD 
Title: “Breast Pathology Latest Research” 
Yale 
19-Jun Laura Collins, MD BIDMC 
26-Jun 
Kumarasen Cooper, MBChB, DPhil, FRCPath 
Title:  “Global Health” 
UPenn 
